← 產業報告目錄

Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Chemicals & Materials出版日期 2025-03-07頁數 240報告編號 CH9322

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The gold nanoparticles market is estimated at USD 0.50 billion in 2024 and is projected to reach USD 1.11 billion by 2029, at a CAGR of 16.3% from 2024 to 2029. Due to its properties such as scalability, cost effectiveness, and precise control over particle size, shape and surface functionality. It is the most popular choice among manufacturers for producing gold nanoparticles. Unlike the other nanoparticles which are physically or biologically processed, chemically processed gold nanoparticles provides high yield production and consistent quality which make them ideal for commercial applications. Chemically processed gold nanoparticles are used in various end use industries such as pharmaceuticals & healthcare, electrical & electronics, chemicals, personal care & cosmetics. ‘‘In terms of value, proton therapy application accounted for the largest share of the overall gold nanoparticles market.’’ Proton therapy application is projected to be the highest market share holding application in the gold nanoparticles market. Proton therapy is one of the groundbreaking advancements in cancer radiotherapy. Despite its advancements proton therapy faces challenges in precision and efficacy, but recent research has highlighted the potential of gold nanoparticles to enhance proton therapy outcomes. Gold nanoparticles have high atomic number and favourable biological properties through which it acts as a radiosensitizers by amplifying generation of secondary electrons and reactive oxygen species upon proton irradiation. This enhances DNA damage in tumor cells while preserving healthy tissues. Thus gold nanoparticles act as a backbone for enhancing proton therapy. “During the forecast period, the gold nanoparticles market in pharmaceuticals & healthcare industry is projected to have highest market share.” During the forecast period from 2024 to 2029, the pharmaceuticals & healthcare industry is expected to have the highest market share in end-use industry in the gold nanoparticles market. The demand for gold nanoparticles is rising in pharmaceuticals & healthacre industry due to its superior performance characteristics, including biocompatibility, optical properties, surface properties and others. Top leading pharmaceutical manufactures such as Gilead Sciences, Inc., and GSK plc. have already adopted gold nanoparticles for vaccine development and kits. Pharmaceuticals & healthcare end use industry is tend to grow with high rate and which will increase the consumption of gold nanoparticles. “During the forecast period, the gold nanoparticles market in Asia Pacific region is projected to be the fastest growing region.” Asia Pacific is the fastest growing market for gold nanoparticles because of its strong demand from pharmaceuticals & healthcare, which is a driving factor for high-performance materials such as gold nanoparticles. The region is dominated by large pharmaceuticals manufacturers, Sun Pharmaceutical Industries Ltd., Sapien Biosciences, which have comprehensive use of gold nanoparticles in various applications. Asia Pacific region has major countries such as India, China which has highest population in the world, and which will tend to increase the demand for pharmaceuticals & healthcare needs. Second, Asia Pacific region is home to various gold nanoparticles manufacturers such as ARITECH CHEMAZONE PVT LTD., Oparin Biotech Pvt Ltd and others. This study has been validated through primary interviews with industry experts globally. These primary sources have been divided into the following three categories: • By Company Type- Tier 1- 60%, Tier 2- 20%, and Tier 3- 20% • By Designation- C Level- 33%, Director Level- 33%, and Managers- 34% • By Region- North America- 20%, Europe- 25%, Asia Pacific- 25%, Middle East & Africa- 15%, and Latin America- 15% The report provides a comprehensive analysis of company profiles: Prominent companies BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US). Research Coverage This research report categorizes the gold nanoparticles market By Process (Physical, Chemical, and Biological), By Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis, and Other Applications), End-Use Industry (Pharmaceuticals & Healthcare, Electrical & Electronics, Chemicals, Personal Care & Cosmetics, and Other End-use Industries), Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America). The scope of the report includes detailed information about the major factors influencing the growth of the gold nanoparticles market, such as drivers, restraints, challenges, and opportunities. A thorough examination of the key industry players has been conducted in order to provide insights into their business overview, solutions, and services, key strategies, contracts, partnerships, and agreements. Product launches, mergers and acquisitions, and recent developments in the gold nanoparticles market are all covered. This report includes a competitive analysis of upcoming startups in the gold nanoparticles market ecosystem. Reasons to buy this report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall gold nanoparticles market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (Increasing demand for gold nanoparticles in electrical & electronics end use industry, unique properties of gold nanoparticles), restraints (Toxicity concerns of gold nanoparticles, stringent regulations impacting market development), opportunities (Increasing in research & development efforts in nanotechnology applications, growing demand for gold nanoparticles in various end use industries), and challenges (High time consumption for certain synthesis methods, growing cost of gold as a raw material) influencing the growth of the gold nanoparticles market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and service launches in the gold nanoparticles market. • Market Development: Comprehensive information about lucrative markets – the report analyses the gold nanoparticles market across varied regions. • Market Diversification: Exhaustive information about services, untapped geographies, recent developments, and investments in the gold nanoparticles market • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), among others in the gold nanoparticles market.
目錄 Table of Contents
1 INTRODUCTION 24 1.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.3 STUDY SCOPE 25 1.3.1 MARKETS COVERED AND REGIONAL SPREAD 25 1.3.2 INCLUSIONS AND EXCLUSIONS OF STUDY 26 1.3.3 YEARS CONSIDERED 27 1.3.4 CURRENCY CONSIDERED 27 1.3.5 UNIT CONSIDERED 27 1.4 STAKEHOLDERS 27 2 RESEARCH METHODOLOGY 28 2.1 RESEARCH DATA 28 2.1.1 SECONDARY DATA 29 2.1.1.1 List of major secondary sources 29 2.1.1.2 Key data from secondary sources 29 2.1.2 PRIMARY DATA 30 2.1.2.1 Key data from primary sources 30 2.1.2.2 Key industry insights 31 2.1.2.3 Breakdown of primary interviews 31 2.2 MARKET SIZE ESTIMATION 32 2.2.1 BOTTOM-UP APPROACH 32 2.2.2 TOP-DOWN APPROACH 32 2.3 DATA TRIANGULATION 33 2.4 RESEARCH ASSUMPTIONS 34 2.5 GROWTH RATE ASSUMPTIONS/FORECAST 34 2.5.1 SUPPLY SIDE 34 2.5.1.1 List of major companies 35 2.5.2 DEMAND SIDE 35 2.6 RISK ASSESSMENT 35 2.7 LIMITATION 35 3 EXECUTIVE SUMMARY 36 4 PREMIUM INSIGHTS 40 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN GOLD NANOPARTICLES MARKET 40 4.2 GOLD NANOPARTICLES MARKET, BY PROCESS 40 4.3 GOLD NANOPARTICLES MARKET, BY APPLICATION 41 4.4 GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY 41 4.5 GOLD NANOPARTICLES MARKET, BY REGION 42 5 MARKET OVERVIEW 43 5.1 INTRODUCTION 43 5.2 MARKET DYNAMICS 43 5.2.1 DRIVERS 44 5.2.1.1 Rising adoption of gold nanoparticles in next-gen electronics: powering smartphones, tablets, touchscreens, and GPS technologies 44 5.2.1.2 High demand for gold nanoparticles in pharmaceutical & healthcare end-use industry 44 5.2.1.3 Unique properties of gold nanoparticles 46 5.2.1.4 Growing demand for oil-soluble gold nanoparticles 46 5.2.2 RESTRAINTS 46 5.2.2.1 Toxicity concerns of gold nanoparticles 46 5.2.2.2 Stringent regulations impacting market development 47 5.2.3 OPPORTUNITIES 48 5.2.3.1 Increase in research & development efforts in nanotechnology applications 48 5.2.3.2 Emerging applications in various end-use industries 48 5.2.4 CHALLENGES 49 5.2.4.1 High time consumption for certain synthesis methods 49 5.2.4.2 Growing price for gold as raw material 49 5.3 PORTER’S FIVE FORCES ANALYSIS 50 5.3.1 THREAT OF NEW ENTRANTS 50 5.3.2 THREAT OF SUBSTITUTES 51 5.3.3 BARGAINING POWER OF BUYERS 51 5.3.4 BARGAINING POWER OF SUPPLIERS 52 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 52 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 53 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 53 5.4.2 BUYING CRITERIA 53 5.5 MACROECONOMIC INDICATORS 55 5.5.1 GLOBAL GDP TRENDS 55 5.6 IMPACT OF GEN AI 56 5.7 VALUE CHAIN ANALYSIS 56 5.7.1 RAW MATERIAL SUPPLIERS (GOLD SOURCE & PRECURSORS) 57 5.7.2 MANUFACTURERS (SYNTHESIS & PROCESSING) 57 5.7.3 SUPPLIERS/DISTRIBUTORS 57 5.7.4 END-USE INDUSTRIES 58 5.8 ECOSYSTEM ANALYSIS 58 5.9 CASE STUDY ANALYSIS 59 5.9.1 ENHANCING CLINICAL EFFECTIVENESS OF GOLD NANOPARTICLES IN MEDICAL APPLICATIONS 59 5.9.2 OPTIMIZING GOLD NANOPARTICLE SYNTHESIS USING DESIGN OF EXPERIMENTS (DOE) 60 5.10 REGULATORY LANDSCAPE 60 5.10.1 REGULATIONS 60 5.10.1.1 Europe 60 5.10.1.2 Asia Pacific 61 5.10.1.3 North America 62 5.10.2 STANDARDS 63 5.10.2.1 ISO 10993 63 5.10.2.2 ISO/TS 27687 63 5.10.2.3 ISO 13321 63 5.10.3 REGULATORY BODIES, GOVERNMENT BODIES, AND OTHER AGENCIES 63 5.11 TECHNOLOGY ANALYSIS 64 5.11.1 KEY TECHNOLOGIES 64 5.11.1.1 Colloidal synthesis and green synthesis methods 64 5.11.1.2 Plasmonic & optical sensing technologies 64 5.11.2 COMPLEMENTARY TECHNOLOGIES 64 5.11.2.1 Microfluidics & Lab-on-a-Chip Devices 64 5.11.3 ADJACENT TECHNOLOGIES 65 5.11.4 QUANTUM DOTS & NANOELECTRONICS 65 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65 5.13 TRADE ANALYSIS 66 5.13.1 EXPORT SCENARIO (HS CODE 284310) 66 5.13.2 IMPORT SCENARIO (HS CODE 284310) 66 5.14 KEY CONFERENCES & EVENTS IN 2024–2025 67 5.15 PRICING ANALYSIS 68 5.15.1 AVERAGE SELLING PRICE TREND, BY REGION 68 5.15.2 AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY, 2022–2029 69 5.15.3 AVERAGE SELLING PRICE OF KEY PLAYERS, BY END-USE INDUSTRY, 2023 70 5.16 INVESTMENT AND FUNDING SCENARIO 70 5.17 PATENT ANALYSIS 71 5.17.1 APPROACH 71 5.17.2 DOCUMENT TYPES 71 5.17.3 PUBLICATION TRENDS, 2013–2023 72 5.17.4 INSIGHTS 72 5.17.5 LEGAL STATUS OF PATENTS 72 5.17.6 JURISDICTION ANALYSIS 73 5.17.7 TOP COMPANIES/APPLICANTS 73 5.17.8 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 74   6 GOLD NANOPARTICLES MARKET, BY PROCESS 75 6.1 INTRODUCTION 76 6.2 PHYSICAL 77 6.2.1 PRODUCTION OF HIGHLY UNIFORM NANOPARTICLES TO DRIVE DEMAND 77 6.3 CHEMICAL 78 6.3.1 WIDE USE IN VARIOUS APPLICATIONS TO DRIVE DEMAND 78 6.4 BIOLOGICAL 78 6.4.1 APPLICATIONS IN BIOMEDICINE, ENVIRONMENTAL SCIENCE, AND CATALYSIS TO DRIVE DEMAND 78 7 GOLD NANOPARTICLES MARKET, BY APPLICATION 79 7.1 INTRODUCTION 80 7.2 IMAGING 82 7.2.1 INCREASING DEMAND FOR IMAGING APPLICATIONS 82 7.3 TARGETED DRUG DELIVERY 83 7.3.1 INCREASING NEED FOR PRECISION DRUG DELIVERY WITH MINIMAL SIDE EFFECTS TO DRIVE DEMAND 83 7.4 PROTON THERAPY 84 7.4.1 GROWING DEMAND FOR HIGHLY EFFECTIVE AND SAFER CANCER TREATMENTS TO FUEL INTEREST IN GNP-ASSISTED PROTON THERAPY 84 7.5 IN-VITRO ASSAYS 84 7.5.1 INCREASING DEMAND FOR RAPID, POINT-OF-CARE DIAGNOSTICS, AND HIGH-THROUGHPUT SCREENING METHODS TO DRIVE MARKET 84 7.6 SENSORS 85 7.6.1 HIGH-PERFORMANCE, PORTABLE, AND REAL-TIME SENSING TECHNOLOGIES TO DRIVE DEMAND 85 7.7 PROBES 85 7.7.1 RISING NEED FOR HIGHLY SENSITIVE AND MULTIPLEXED DETECTION PLATFORMS TO DRIVE DEMAND 85 7.8 CATALYSIS 86 7.8.1 HIGH STABILITY, RECYCLABILITY, AND ABILITY TO OPERATE UNDER MILD REACTION CONDITIONS TO DRIVE DEMAND FOR GOLD NANOPARTICLES IN CATALYSIS APPLICATION 86 7.9 OTHER APPLICATIONS 87 7.9.1 GROWING NEED FOR PRECISION MEDICINE, ADVANCED BIOSENSORS, AND SUSTAINABLE SOLUTIONS TO DRIVE DEMAND 87 8 GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY 88 8.1 INTRODUCTION 89 8.2 PHARMACEUTICALS & HEALTHCARE 91 8.2.1 TARGETED DRUG DELIVERY SYSTEM AND DIAGNOSTIC APPLICATIONS TO INCREASE DEMAND FOR GOLD NANOPARTICLES 91 8.3 ELECTRICAL & ELECTRONICS 91 8.3.1 CONDUCTIVITY AND FLEXIBILITY TO DRIVE DEMAND IN ELECTRICAL AND ELECTRONICS INDUSTRIES 91 8.4 CHEMICALS 92 8.4.1 CATALYSIS AND GREEN CHEMISTRY APPLICATION TO DRIVE DEMAND 92 8.5 PERSONAL CARE & COSMETICS 92 8.5.1 ANTIBACTERIAL, ANTIFUNGAL, ANTI-INFLAMMATORY, AND REGENERATIVE PROPERTIES OF GOLD NANOPARTICLES TO DRIVE DEMAND 92 8.6 OTHER END-USE INDUSTRIES 93 9 GOLD NANOPARTICLES MARKET, BY REGION 94 9.1 INTRODUCTION 95 9.2 NORTH AMERICA 97 9.2.1 US 102 9.2.1.1 Growing healthcare and cosmetics industries to boost market 102 9.2.2 CANADA 104 9.2.2.1 Demand from growing chemical, healthcare, and cosmetics industries to propel market 104 9.2.3 MEXICO 106 9.2.3.1 Healthcare industry to drive market 106 9.3 EUROPE 108 9.3.1 GERMANY 114 9.3.1.1 Rising investment in healthcare sector to drive demand for gold nanoparticles 114 9.3.2 FRANCE 115 9.3.2.1 Increasing utilization of gold nanoparticles in various end-use industries to boost market 115 9.3.3 SPAIN 117 9.3.3.1 Opportunities in pharmaceutical & healthcare industry to fuel demand 117 9.3.4 UK 119 9.3.4.1 Demand for gold nanoparticles in healthcare industry to propel market 119 9.3.5 ITALY 120 9.3.5.1 Chemicals, pharmaceuticals, and food & beverage industries to boost demand 120 9.3.6 REST OF EUROPE 122 9.4 ASIA PACIFIC 124 9.4.1 CHINA 129 9.4.1.1 High requirement of gold nanoparticles in various end-use industries to drive demand 129 9.4.2 JAPAN 131 9.4.2.1 Gold nanoparticles’ requirement in various end-use industries to drive market 131 9.4.3 INDIA 133 9.4.3.1 Growth of pharmaceutical industry to increase demand 133 9.4.4 SOUTH KOREA 134 9.4.4.1 Strategic focus on healthcare industry to drive growth 134 9.4.5 REST OF ASIA PACIFIC 136 9.5 MIDDLE EAST & AFRICA 138 9.5.1 GCC COUNTRIES 144 9.5.1.1 UAE 145 9.5.1.1.1 Significantly expanding healthcare sector to propel market growth 145 9.5.1.2 Saudi Arabia 147 9.5.1.2.1 Improvised healthcare sector to drive demand 147 9.5.1.3 Rest of GCC countries 148 9.5.2 TÜRKIYE 150 9.5.2.1 Advancement in nanotechnology to increase demand 150 9.5.3 SOUTH AFRICA 152 9.5.3.1 Diversified economy to drive growth 152 9.5.4 REST OF MIDDLE EAST & AFRICA 153 9.6 SOUTH AMERICA 155 9.6.1 BRAZIL 160 9.6.1.1 Increasing investments in electronic industry to drive growth 160 9.6.2 ARGENTINA 162 9.6.2.1 Growing pharmaceutical sector to drive market 162 9.6.3 REST OF SOUTH AMERICA 164 10 COMPETITIVE LANDSCAPE 166 10.1 OVERVIEW 166 10.2 KEY PLAYER STRATEGIES 166 10.3 REVENUE ANALYSIS, 2021–2023 167 10.4 MARKET SHARE ANALYSIS 168 10.5 COMPANY VALUATION AND FINANCIAL METRICS 171 10.6 BRAND/PRODUCT COMPARISON ANALYSIS 172 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 173 10.7.1 STARS 173 10.7.2 EMERGING LEADERS 173 10.7.3 PERVASIVE PLAYERS 174 10.7.4 PARTICIPANTS 174 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 175 10.7.5.1 Company footprint 175 10.7.5.2 Region footprint 176 10.7.5.3 Process footprint 177 10.7.5.4 Applications 178 10.7.5.5 End-use industry footprint 179 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 180 10.8.1 PROGRESSIVE COMPANIES 180 10.8.2 RESPONSIVE COMPANIES 180 10.8.3 DYNAMIC COMPANIES 180 10.8.4 STARTING BLOCKS 180 10.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2023 182 10.8.5.1 Detailed list of key startups/SMEs 182 10.8.5.2 Competitive benchmarking of key startups/SMEs 183 10.9 COMPETITIVE SCENARIO AND TRENDS 184 10.9.1 PRODUCT LAUNCHES 184 10.9.2 EXPANSIONS 184 10.9.3 DEALS 185 11 COMPANY PROFILES 186 11.1 KEY PLAYERS 186 11.1.1 BBI SOLUTIONS 186 11.1.1.1 Business overview 186 11.1.1.2 Products/Solutions/Services offered 186 11.1.1.3 Recent developments 187 11.1.1.3.1 Deals 187 11.1.1.4 MnM view 188 11.1.1.4.1 Right to win 188 11.1.1.4.2 Strategic choices 188 11.1.1.4.3 Weaknesses and competitive threats 188 11.1.2 CYTODIAGNOSTICS INC 189 11.1.2.1 Business overview 189 11.1.2.2 Products/Solutions/Services offered 189 11.1.2.3 MnM view 191 11.1.2.3.1 Right to win 191 11.1.2.3.2 Strategic choices 191 11.1.2.3.3 Weaknesses and competitive threats 192 11.1.3 FORTIS LIFE SCIENCES, LLC. 193 11.1.3.1 Business overview 193 11.1.3.2 Products/Solutions/Services offered 193 11.1.3.3 Recent developments 195 11.1.3.3.1 Deals 195 11.1.3.4 MnM view 196 11.1.3.4.1 Right to win 196 11.1.3.4.2 Strategic choices 196 11.1.3.4.3 Weaknesses and competitive threats 196 11.1.4 MELIORUM TECHNOLOGIES, INC 197 11.1.4.1 Business overview 197 11.1.4.2 Products/Solutions/Services offered 197 11.1.4.3 MnM view 198   11.1.5 JOHNSON MATTHEY 199 11.1.5.1 Business overview 199 11.1.5.2 Products/Solutions/Services offered 200 11.1.5.3 MnM view 201 11.1.6 TANAKA PRECIOUS METAL GROUP CO. 202 11.1.6.1 Business overview 202 11.1.6.2 Products/Solutions/Services offered 203 11.1.6.3 Recent developments 203 11.1.6.3.1 Product Launch 203 11.1.6.4 MnM view 204 11.1.6.4.1 Right to win 204 11.1.6.4.2 Strategic choices 204 11.1.6.4.3 Weaknesses and competitive threats 204 11.1.7 SIGMA ALDRICH (MERCK KGAA) 205 11.1.7.1 Business overview 205 11.1.7.2 Products/Solutions/Services offered 206 11.1.7.3 Recent developments 207 11.1.7.3.1 Expansions 207 11.1.7.4 MnM view 207 11.1.7.4.1 Right to win 207 11.1.7.4.2 Strategic choices 208 11.1.7.4.3 Weaknesses and competitive threats 208 11.1.8 NANOPARTZ INC. 209 11.1.8.1 Business overview 209 11.1.8.2 Products/Solutions/Services offered 209 11.1.8.3 MnM view 210 11.1.9 CD BIOPARTICLES 211 11.1.9.1 Business overview 211 11.1.9.2 Products/Solutions/Services offered 211 11.1.9.3 MnM view 213 11.1.10 NANO LABS 214 11.1.10.1 Business overview 214 11.1.10.2 Products/Solutions/Services offered 214 11.1.10.3 MnM view 214 11.1.11 NANOCS INC 215 11.1.11.1 Business overview 215 11.1.11.2 Products/Solutions/Services offered 215 11.1.11.3 MnM view 216 11.2 OTHER PLAYERS 217 11.2.1 NANOHYBRIDS 217 11.2.2 FORTIS LIFE SCIENCES 218 11.2.3 SONA NANOTECH 219 11.2.4 SISCO RESEARCH LABORATORIES PVT, LTD. 220 11.2.5 NANOPROBES, INC 221 11.2.6 AMERICAN ELEMENTS 222 11.2.7 TORSKAL 223 11.2.8 ABCAM LIMITED 224 11.2.9 PARTICULAR GMBH 225 11.2.10 DONGGUAN SAT NANO TECHNOLOGY MATERIAL CO., LTD 226 11.2.11 NANO FLOW 227 11.2.12 STREM CATALOG 228 11.2.13 NANORH 229 11.2.14 SKYSPRING NANOMATERIALS, INC 230 11.2.15 AURION 231 11.2.16 NNCRYSTAL US CORPORATION 232 12 APPENDIX 233 12.1 DISCUSSION GUIDE 233 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 236 12.3 CUSTOMIZATION OPTIONS 238 12.4 RELATED REPORTS 238 12.5 AUTHOR DETAILS 239
圖表清單 List of Tables & Figures
TABLE 1 GOLD NANOPARTICLES MARKET: INCLUSIONS AND EXCLUSIONS 26 TABLE 2 GOLD NANOPARTICLES MARKET: PORTER’S FIVE FORCES 52 TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END-USE INDUSTRIES (%) 53 TABLE 4 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES 54 TABLE 5 PROJECTED REAL GDP GROWTH (ANNUAL PERCENT CHANGE) OF KEY COUNTRIES, 2021–2029 55 TABLE 6 PHARMACEUTICALS SALES OF KEY REGIONS (PERCENTAGE) 2021 56 TABLE 7 GOLD NANOPARTICLES MARKET: ROLE OF PLAYERS IN ECOSYSTEM 58 TABLE 8 GOLD NANOPARTICLES MARKET: LIST OF SUPPLIERS FACING REGULATORY CHALLENGES AND APPROVALS 62 TABLE 9 GOLD NANOPARTICLES MARKET: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 10 GOLD NANOPARTICLES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024–2025 67 TABLE 11 INDICATIVE AVERAGE SELLING PRICE OF GOLD NANOPARTICLES, BY REGION (USD/KG) 68 TABLE 12 INDICATIVE AVERAGE SELLING PRICE OF GOLD NANOPARTICLES, BY END USE INDUSTRY (USD/KG) 69 TABLE 13 TOTAL PATENT COUNT 71 TABLE 14 PATENTS BY MERCK KGAA 74 TABLE 15 TOP 10 PATENT OWNERS IN LAST 10 YEARS 74 TABLE 16 GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION) 76 TABLE 17 GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION) 77 TABLE 18 GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG) 77 TABLE 19 GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG) 77 TABLE 20 GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 81 TABLE 21 GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 81 TABLE 22 GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG) 81 TABLE 23 GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG) 82 TABLE 24 GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES, 2021–2023 (USD MILLION) 89 TABLE 25 GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES, 2024–2029 (USD MILLION) 90 TABLE 26 GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES, 2021–2023 (KG) 90 TABLE 27 GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES, 2024–2029 (KG) 90 TABLE 28 GOLD NANOPARTICLES MARKET, BY REGION, 2021–2023 (USD MILLION) 95 TABLE 29 GOLD NANOPARTICLES MARKET, BY REGION, 2024–2029 (USD MILLION) 96 TABLE 30 GOLD NANOPARTICLES MARKET, BY REGION, 2021–2023 (KG) 96 TABLE 31 GOLD NANOPARTICLES MARKET, BY REGION, 2024–2029 (KG) 96 TABLE 32 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 98 TABLE 33 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 98 TABLE 34 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG) 98 TABLE 35 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG) 98 TABLE 36 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION) 99 TABLE 37 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION) 99 TABLE 38 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG) 99 TABLE 39 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG) 99 TABLE 40 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 100 TABLE 41 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 100 TABLE 42 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG) 100 TABLE 43 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG) 101 TABLE 44 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 101 TABLE 45 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 101 TABLE 46 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 102 TABLE 47 NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 102 TABLE 48 US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 103 TABLE 49 US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 103 TABLE 50 US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 103 TABLE 51 US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 104 TABLE 52 CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 105 TABLE 53 CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 105 TABLE 54 CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 105 TABLE 55 CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 106 TABLE 56 MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 106 TABLE 57 MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 107 TABLE 58 MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 107 TABLE 59 MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 107 TABLE 60 EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 109 TABLE 61 EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 109 TABLE 62 EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG) 109 TABLE 63 EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG) 110 TABLE 64 EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION) 110 TABLE 65 EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION) 110 TABLE 66 EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG) 110 TABLE 67 EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG) 111 TABLE 68 EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 111 TABLE 69 EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 111 TABLE 70 EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG) 112 TABLE 71 EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG) 112 TABLE 72 EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 112 TABLE 73 EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 113 TABLE 74 EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 113 TABLE 75 EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 113 TABLE 76 GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 114 TABLE 77 GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 114 TABLE 78 GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 115 TABLE 79 GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 115 TABLE 80 FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 116 TABLE 81 FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 116 TABLE 82 FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 116 TABLE 83 FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 117 TABLE 84 SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 117 TABLE 85 SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 118 TABLE 86 SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 118 TABLE 87 SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 118 TABLE 88 UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 119 TABLE 89 UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 119 TABLE 90 UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 120 TABLE 91 UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 120 TABLE 92 ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 121 TABLE 93 ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 121 TABLE 94 ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 121 TABLE 95 ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 122 TABLE 96 REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 122 TABLE 97 REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 123 TABLE 98 REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 123 TABLE 99 REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 123 TABLE 100 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 124 TABLE 101 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 125 TABLE 102 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG) 125 TABLE 103 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG) 125 TABLE 104 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION) 125 TABLE 105 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION) 126 TABLE 106 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG) 126 TABLE 107 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG) 126 TABLE 108 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 126 TABLE 109 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 127 TABLE 110 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG) 127 TABLE 111 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG) 128 TABLE 112 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 128 TABLE 113 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 128 TABLE 114 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 129 TABLE 115 ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 129 TABLE 116 CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 130 TABLE 117 CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 130 TABLE 118 CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 130 TABLE 119 CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 131 TABLE 120 JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 131 TABLE 121 JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 132 TABLE 122 JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 132 TABLE 123 JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 132 TABLE 124 INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 133 TABLE 125 INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 133 TABLE 126 INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 134 TABLE 127 INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 134 TABLE 128 SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 135 TABLE 129 SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 135 TABLE 130 SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 135 TABLE 131 SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 136 TABLE 132 REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 136 TABLE 133 REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 137 TABLE 134 REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 137 TABLE 135 REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 137 TABLE 136 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 138 TABLE 137 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 138 TABLE 138 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG) 139 TABLE 139 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG) 139 TABLE 140 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION) 139 TABLE 141 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION) 140 TABLE 142 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG) 140 TABLE 143 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG) 140 TABLE 144 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 141 TABLE 145 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 141 TABLE 146 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG) 142 TABLE 147 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG) 142 TABLE 148 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 142 TABLE 149 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 143 TABLE 150 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 143 TABLE 151 MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 143 TABLE 152 GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 144 TABLE 153 GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 144 TABLE 154 GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 144 TABLE 155 GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 145 TABLE 156 UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 145 TABLE 157 UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 146 TABLE 158 UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 146 TABLE 159 UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 146 TABLE 160 SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 147 TABLE 161 SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 147 TABLE 162 SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 148 TABLE 163 SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 148 TABLE 164 REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 149 TABLE 165 REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 149 TABLE 166 REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 149 TABLE 167 REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 150 TABLE 168 TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 150 TABLE 169 TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 151 TABLE 170 TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 151 TABLE 171 TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 151 TABLE 172 SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 152 TABLE 173 SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 152 TABLE 174 SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 153 TABLE 175 SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 153 TABLE 176 REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 154 TABLE 177 REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 154 TABLE 178 REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 154 TABLE 179 REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 155 TABLE 180 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 155 TABLE 181 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 155 TABLE 182 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG) 156 TABLE 183 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG) 156 TABLE 184 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION) 156 TABLE 185 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION) 156 TABLE 186 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG) 157 TABLE 187 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG) 157 TABLE 188 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 157 TABLE 189 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 158 TABLE 190 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG) 158 TABLE 191 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG) 159 TABLE 192 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 159 TABLE 193 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 159 TABLE 194 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 160 TABLE 195 SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 160 TABLE 196 BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 161 TABLE 197 BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 161 TABLE 198 BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 161 TABLE 199 BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 162 TABLE 200 ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 162 TABLE 201 ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 163 TABLE 202 ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 163 TABLE 203 ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 163 TABLE 204 REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 164 TABLE 205 REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 165 TABLE 206 REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 165 TABLE 207 REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 165 TABLE 208 GOLD NANOPARTICLES MARKET: DEGREE OF COMPETITION 169 TABLE 209 GOLD NANOPARTICLES MARKET: REGIONAL FOOTPRINT 176 TABLE 210 GOLD NANOPARTICLES MARKET: PROCESS FOOTPRINT 177 TABLE 211 GOLD NANOPARTICLES MARKET: APPLICATION FOOTPRINT 178 TABLE 212 GOLD NANOPARTICLES MARKET: END-USE INDUSTRY FOOTPRINT 179 TABLE 213 GOLD NANOPARTICLES: KEY STARTUPS/SMES 182 TABLE 214 GOLD NANOPARTICLES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 183 TABLE 215 GOLD NANOPARTICLES MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2024 184 TABLE 216 GOLD NANOPARTICLES MARKET: EXPANSIONS, JANUARY 2020–APRIL 2024 184 TABLE 217 GOLD NANOPARTICLES MARKET: DEALS, JANUARY 2020–APRIL 2024 185 TABLE 218 BBI SOLUTIONS: COMPANY OVERVIEW 186 TABLE 219 BBI SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 186 TABLE 220 BBI SOLUTIONS: DEALS, JANUARY 2019–NOVEMBER 2024 187 TABLE 221 CYTODIAGNOSTICS INC: COMPANY OVERVIEW 189 TABLE 222 CYTODIAGNOSTICS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 189 TABLE 223 FORTIS LIFE SCIENCES, LLC.: COMPANY OVERVIEW 193 TABLE 224 FORTIS LIFE SCIENCES, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 193 TABLE 225 FORTIS LIFE SCIENCES, LLC.: DEALS, JANUARY 2019–NOVEMBER 2024 195 TABLE 226 MELIORUM TECHNOLOGIES, INC: COMPANY OVERVIEW 197 TABLE 227 MELIORUM TECHNOLOGIES, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 197 TABLE 228 JOHNSON MATTHEY: COMPANY OVERVIEW 199 TABLE 229 JOHNSON MATTHEY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200 TABLE 230 TANAKA PRECIOUS METAL GROUP CO.: COMPANY OVERVIEW 202 TABLE 231 TANAKA PRECIOUS METAL GROUP CO.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED 203 TABLE 232 TANAKA PRECIOUS METAL GROUP CO.: PRODUCT LAUNCHES, JANUARY 2019–NOVEMBER 2024 203 TABLE 233 SIGMA ALDRICH: COMPANY OVERVIEW 205 TABLE 234 SIGMA ALDRICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 206 TABLE 235 SIGMA ALDRICH: EXPANSIONS, JANUARY 2019–NOVEMBER 2024 207 TABLE 236 NANOPARTZ INC.: COMPANY OVERVIEW 209 TABLE 237 NANOPARTZ INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 209 TABLE 238 CD BIOPARTICLES: COMPANY OVERVIEW 211 TABLE 239 CD BIOPARTICLES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 211 TABLE 240 NANO LABS: COMPANY OVERVIEW 214 TABLE 241 NANO LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214 TABLE 242 NANOCS INC: COMPANY OVERVIEW 215 TABLE 243 NANOCS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 215 TABLE 244 NANOHYBRIDS: COMPANY OVERVIEW 217 TABLE 245 FORTIS LIFE SCIENCES: COMPANY OVERVIEW 218 TABLE 246 SONA NANOTECH: COMPANY OVERVIEW 219 TABLE 247 SISCO RESEARCH LABORATORIES PVT, LTD.: COMPANY OVERVIEW 220 TABLE 248 NANOPROBES, INC: COMPANY OVERVIEW 221 TABLE 249 AMERICAN ELEMENTS: COMPANY OVERVIEW 222 TABLE 250 TORSKAL: COMPANY OVERVIEW 223 TABLE 251 ABCAM LIMITED: COMPANY OVERVIEW 224 TABLE 252 PARTICULAR GMBH: COMPANY OVERVIEW 225 TABLE 253 DONGGUAN SAT NANO TECHNOLOGY MATERIAL CO., LTD: COMPANY OVERVIEW 226 TABLE 254 NANO FLOW: COMPANY OVERVIEW 227 TABLE 255 STREM CATALOG: COMPANY OVERVIEW 228 TABLE 256 NANORH: COMPANY OVERVIEW 229 TABLE 257 SKYSPRING NANOMATERIALS, INC: COMPANY OVERVIEW 230 TABLE 258 AURION: COMPANY OVERVIEW 231 TABLE 259 NNCRYSTAL US CORPORATION: COMPANY OVERVIEW 232 _ FIGURE 1 GOLD NANOPARTICLES MARKET SEGMENTATION 25 FIGURE 2 GOLD NANOPARTICLES MARKET: RESEARCH DESIGN 28 FIGURE 3 GOLD NANOPARTICLES MARKET: BOTTOM-UP APPROACH 32 FIGURE 4 GOLD NANOPARTICLES MARKET: TOP-DOWN APPROACH 32 FIGURE 5 GOLD NANOPARTICLES MARKET: DATA TRIANGULATION 33 FIGURE 6 CHEMICAL PROCESS TO DOMINATE MARKET DURING FORECAST PERIOD 36 FIGURE 7 PROTON THERAPY TO CAPTURE LARGEST MARKET SHARE DURING FORECAST PERIOD 37 FIGURE 8 PHARMACEUTICALS & HEALTHCARE TO BE LARGEST END-USE INDUSTRY DURING FORECAST PERIOD 38 FIGURE 9 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 38 FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING GOLD NANOPARTICLES MARKET DURING FORECAST PERIOD 40 FIGURE 11 CHEMICAL PROCESS TO BE LARGER PROCESS DURING FORECAST PERIOD 40 FIGURE 12 PROTON THERAPY TO CAPTURE LARGEST SHARE DURING FORECAST PERIOD 41 FIGURE 13 PHARMACEUTICAL & HEALTHCARE INDUSTRY TO LEAD MARKET DURING FORECAST PERIOD 41 FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 42 FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN GOLD NANOPARTICLES MARKET 43 FIGURE 16 GOLD NANOPARTICLES MARKET: PORTER’S FIVE FORCES ANALYSIS 50 FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF KEY END-USE INDUSTRIES 53 FIGURE 18 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES 54 FIGURE 19 OVERVIEW OF GOLD NANOPARTICLES VALUE CHAIN 57 FIGURE 20 GOLD NANOPARTICLES MARKET: ECOSYSTEM 58 FIGURE 21 GOLD NANOPARTICLES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65 FIGURE 22 COUNTRY-WISE EXPORT TRADE VALUE FOR HS CODE 284310 (USD THOUSAND) 66 FIGURE 23 COUNTRY-WISE IMPORT TRADE VALUE FOR HS CODE 284310 (USD THOUSAND) 67 FIGURE 24 AVERAGE SELLING PRICE, BY REGION (USD/KG), 2022–2029 68 FIGURE 25 AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY (USD/KG), 2022–2029 69 FIGURE 26 AVERAGE SELLING PRICE OF KEY PLAYERS, BY END-USE INDUSTRY (USD/KG), 2023 70 FIGURE 27 INVESTMENT AND FUNDING SCENARIO 70 FIGURE 28 TOTAL NUMBER OF PATENTS 71 FIGURE 29 NUMBER OF PATENTS YEAR-WISE FROM 2013–2023 72 FIGURE 30 PATENT ANALYSIS, BY LEGAL STATUS 72 FIGURE 31 TOP JURISDICTION, BY DOCUMENT 73 FIGURE 32 TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS 73 FIGURE 33 CHEMICAL PROCESS TO ACCOUNT FOR LARGEST MARKET SHARE 76 FIGURE 34 PROTON THERAPY APPLICATION TO ACCOUNT FOR LARGEST MARKET SHARE 80 FIGURE 35 ELECTRICAL & ELECTRONICS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 89 FIGURE 36 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 95 FIGURE 37 NORTH AMERICA: GOLD NANOPARTICLES MARKET SNAPSHOT 97 FIGURE 39 ASIA PACIFIC: GOLD NANOPARTICLES MARKET SNAPSHOT 124 FIGURE 40 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GOLD NANOPARTICLES MARKET BETWEEN 2020 AND 2024 167 FIGURE 41 REVENUE ANALYSIS OF KEY COMPANIES IN GOLD NANOPARTICLES MARKET, 2019–2023 168 FIGURE 42 SHARES OF TOP FIVE COMPANIES IN GOLD NANOPARTICLES MARKET, 2023 168 FIGURE 43 COMPANY VALUATION OF KEY COMPANIES IN GOLD NANOPARTICLES MARKET, 2023 171 FIGURE 44 FINANCIAL METRICS OF KEY COMPANIES IN GOLD NANOPARTICLES MARKET, 2023 172 FIGURE 45 GOLD NANOPARTICLES MARKET: BRAND/PRODUCT COMPARISON 173 FIGURE 46 GOLD NANOPARTICLES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 174 FIGURE 47 GOLD NANOPARTICLES MARKET: COMPANY FOOTPRINT 175 FIGURE 48 GOLD NANOPARTICLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 181 FIGURE 49 JOHNSON MATTHEY: COMPANY SNAPSHOT 200 FIGURE 50 TANAKA PRECIOUS METAL GROUP CO.: COMPANY SNAPSHOT 202 FIGURE 51 SIGMA ALDRICH: COMPANY SNAPSHOT 206

同分類最新報告（化學與材料）

查看化學與材料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們